Roccaro et al. demonstrated that miR-15a/16-1 regulates MM cell proliferation in vitro and in vivo by inhibiting the AKT serine/threonine protein kinase, ribosomal S6 protein, MAP kinases and the NF-kB MAP3KIP3 activator [43]. This evidence concerns the gene NFKB1 and Miyoshi myopathy.